SV Health Investors discuss the firm’s new $90M early-stage Medtech Convergence Fund

in SV News

Author: Lisa Carmel

Publication: Ximedica

Forging where others are tentative to trod, SV Health Investors, in partnership with Aaron Sandoski from Norwich Ventures, and Tejin launched a $90M Medtech Convergence Fund, focused on early stage investments in April 2020. Curious about the intent and vision, I connected with Paul LaViolette, Managing Partner and COO to learn more. Disclosure: SV Health Investors is majority share owner of Ximedica.

View the article
Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.